How to expand the US economy
In “Priority Technologies,” MIT faculty examine key areas of innovation that can drive American prosperity and security — now and in the decades ahead.
In “Priority Technologies,” MIT faculty examine key areas of innovation that can drive American prosperity and security — now and in the decades ahead.
Founded by Tristan Bepler PhD ’20 and former MIT professor Tim Lu PhD ’07, OpenProtein.AI offers researchers open-source models and other tools for protein engineering.
At MIT, former U.S. ambassador to China Nicholas Burns highlights climate change as an area for diplomatic engagement, while exploring areas including China's emphasis on STEM education.
Offering substantial prize funding alongside workshops, classes, and mentorship, the initiative helps translate early-stage biotech research into venture-ready innovation.
In STS.059 (The Bioeconomy and Society), students explore the social and political factors at work in the biology, biotech, and biological engineering sectors.
MagMix, an onboard mixing device, enables scalable manufacturing of 3D-printed tissues.
In the 2025 Dresselhaus Lecture, the materials scientist describes her work 3D printing soft materials ranging from robots to human tissues.
The approach could transform large-scale biomanufacturing by enabling automated and contamination-conscious workflows for cell therapies, tissue engineering, and regenerative medicine.
Cultured from induced pluripotent stem cells, “miBrains” integrate all major brain cell types and model brain structures, cellular interactions, activity, and pathological features.
MIT researchers created microscopic wireless electronic devices that travel through blood and implant in target brain regions, where they provide electrical stimulation.
Selective crystallization can greatly improve the purity, selectivity, and active yield of viral vector-based gene therapy drugs, MIT study finds.
Twelve START.nano companies competed for the grand prize of nanoBucks to be used at MIT.nano’s facilities.
The gathering of Biogen and MIT employees, business leaders, and public officials celebrated the first building to be constructed at Kendall Common.
The method enhances 3D bioprinting capabilities, accelerating process optimization for real-world applications in tissue engineering.
MIT spinout Tissium recently secured FDA marketing authorization of a biopolymer platform for nerve repair.